Submitting Abstracts

The extended deadline for submitting abstracts has closed as of 15 February 2023, GMT-8. 

Submission Process

• All abstracts must be submitted via the abstract portal.
• Authors will be notified about the receipt of their abstract by e-mail immediately. In case you did not receive confirmation within 24 hours, please check your spam folder. For assistance, please email apcmbe2023@csmbe.org
• Authors are able to edit their abstracts before the submission deadline. No further edits will be permitted after deadline.
• All correspondences concerning submitted abstracts will be sent via email to submitting author’s e-mail address.

Abstract Format

• The length of the abstracts in plain text should not exceed 300 words.
• Please keep the title of the abstract brief, clearly indicating the nature of the work to be presented. Use a capital letter for the first letter of each word in the title (Prepositions and pronouns are excluded).
• Names of the authors: Submit the full given name(s) and the family name. Do not include degrees or professional titles.

Conflict of Interest

When an author or the institution of the author has a relationship, financial or otherwise, with individuals or organizations that could influence the author’s work inappropriately, a conflict of interest may exist.

Examples of potential conflicts of interest may include but are not limited to academic, personal, or political relationships; employment; consultancies or honoraria; and finical connections such as stock ownership and funding. Although an author may not feel that there are conflicts, disclosure of relationships and interests that could be viewed by others as conflicts of interest affords a more transparent and prudent process. All authors must disclose any actual or potential conflict of interest. The Book of Abstracts will publish such disclosures if judged to be important to readers.

Statement of Informed Consent

Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the abstract/manuscript to be published or in presentation slides.

Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

Statement of Human and Animal Rights

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

Contact

For assistance, please contact apcmbe2023@csbme.org